Hearing Loss News and Research RSS Feed - Hearing Loss News and Research

Hearing loss, impairment or deafness may be of two major types: one that develops some time in life, one that a baby is born with – or congenital deafness. Most commonly, hearing loss is seen with age or is caused by exposure to loud noises.
People with common form of hearing loss may benefit from hybrid cochlear implant devices

People with common form of hearing loss may benefit from hybrid cochlear implant devices

People with a common form of hearing loss not helped by hearing aids achieved significant and sometimes profound improvements in their hearing and understanding of speech with hybrid cochlear implant devices, according to a new multicenter study led by specialists at NYU Langone Medical Center. [More]

Simple procedure with nasal balloon can reduce impact of hearing loss in children

For children with a common middle-ear problem, a simple procedure with a nasal balloon can reduce the impact of hearing loss and avoid unnecessary and ineffective use of antibiotics, according to a new study led by researchers from the University of Southampton. [More]

New study contributes to understanding of inner ear development

Unlike birds and amphibians, mammals can't recover lost hearing. In people, the cells of the inner ear responsible for detecting sound and transmitting those signals to the brain form during early stages of development and can't be replaced if lost due to illness, injury or aging. [More]
Transcranial magnetic stimulation holds promise for tinnitus patients

Transcranial magnetic stimulation holds promise for tinnitus patients

In the largest U.S. clinical trial of its kind funded by the Veterans Affairs Rehabilitation Research and Development Service, researchers at the VA Portland Medical Center and Oregon Health & Science University found that transcranial magnetic stimulation significantly improved tinnitus symptoms for more than half of study participants. [More]

Brett Lee named Cochlear's first Global Hearing Ambassador

Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss. [More]
New incoming nerve cell connections could be contributing to age-related hearing loss, say Johns Hopkins scientists

New incoming nerve cell connections could be contributing to age-related hearing loss, say Johns Hopkins scientists

Conventional wisdom has long blamed age-related hearing loss almost entirely on the death of sensory hair cells in the inner ear, but research from neuroscientists at Johns Hopkins has provided new information about the workings of nerve cells that suggests otherwise. [More]
Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

Turtle Beach Corporation, the leading-edge audio technology company, today announced a new partnership with Audiology Management Group, Inc. for HyperSound Clear, the Company's groundbreaking hearing healthcare product planned to launch later this year. [More]
High-frequency tympanometry testing can help identify middle-ear problems in newborn babies

High-frequency tympanometry testing can help identify middle-ear problems in newborn babies

Screening newborn babies who are in the neonatal intensive care unit (NICU) using a testing process called high-frequency tympanometry can help identify middle-ear problems earlier, according to newly published research from a local team of researchers. [More]
Dr. Jian-Dong Li receives $1.6 million to develop novel therapeutic targets to treat middle-ear infections

Dr. Jian-Dong Li receives $1.6 million to develop novel therapeutic targets to treat middle-ear infections

Dr. Jian-Dong Li, a professor and director of the Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, $1.6 million federal grant to develop novel anti-inflammatory therapeutics against middle-ear infections. [More]
Practice caution with Fourth of July fireworks, urge Vanderbilt doctors

Practice caution with Fourth of July fireworks, urge Vanderbilt doctors

Fireworks and the Fourth of July can be a dangerous mix. Doctors at Vanderbilt University Medical Center urge caution with consumer fireworks and suggest leaving these displays to the experts. [More]
Rare genetic variants in A2ML1 gene responsible for chronic middle ear infections, say researchers

Rare genetic variants in A2ML1 gene responsible for chronic middle ear infections, say researchers

Many parents have heard the night-time cry of "my ear hurts." For some children, this might happen frequently beginning in infancy and even persist into adulthood. An international consortium led by those at Baylor College of Medicine may have taken the first step on the road to understanding why only some people get frequent painful or chronic middle ear infections. The culprit may be rare genetic variants in a gene called A2ML1. [More]
Cochlear Nucleus 6 Sound Processor approved by FDA for use with Nucleus 22 Cochlear Implant

Cochlear Nucleus 6 Sound Processor approved by FDA for use with Nucleus 22 Cochlear Implant

Cochlear Limited, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Cochlear™ Nucleus® 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning (over 20 years in some cases) access to the latest breakthroughs in true wireless and automatic hearing. Released in 1985, the Nucleus 22 Implant was the first commercially available multi-channel cochlear implant in the world. [More]
Loyola otolaryngologist emphasizes need to protect children's ears from loud fireworks

Loyola otolaryngologist emphasizes need to protect children's ears from loud fireworks

They've packed the sunscreen and bug spray to protect their little ones while enjoying a Fourth of July celebration, but many parents don't think about the potential damage that the loud fireworks can do to a young child's ears. [More]
Researchers study effect of graphic novella in preventing hearing loss among Spanish-speaking ag workers

Researchers study effect of graphic novella in preventing hearing loss among Spanish-speaking ag workers

Graphic novels usually conjure up dark images of superheroes cleaning up the mean streets of Gotham or Metropolis. Mark Guiberson may not be a superhero, but he is trying to improve life for a particular population. [More]
People across the world are living longer but spending more time in ill health

People across the world are living longer but spending more time in ill health

People across the world are living longer but spending more time in ill health as rates of nonfatal diseases and injuries - including diabetes and hearing loss - decline more slowly than death rates, according to a new analysis of 301 diseases and injuries in 188 countries. [More]
GBD analysis shows over 95% of global population has health problems

GBD analysis shows over 95% of global population has health problems

Just one in 20 people worldwide (4·3%) had no health problems in 2013, with a third of the world's population (2·3 billion individuals) experiencing more than five ailments, according to a major new analysis from the Global Burden of Disease Study (GBD) 2013, published in The Lancet. [More]
Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21"). [More]
Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec Pharmaceuticals, Inc., announced the presentation of positive interim results from a poster presented today entitled, "Anti-tumor efficacy in SIOPEL6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB)." [More]
New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool. The new TB-Profiler tool, developed by a team of scientists led by Dr Taane Clark at the London School of Hygiene & Tropical Medicine, analyses and interprets genome sequence data to predict resistance to 11 drugs used for the treatment of TB. [More]
Hearing impairment more prevalent among Hispanic/Latino adults

Hearing impairment more prevalent among Hispanic/Latino adults

Hearing impairment was more prevalent among men and older individuals in a study of U.S. Hispanic/Latino adults, according to a report published online by JAMA Otolaryngology-Head and Neck Surgery. [More]
Advertisement
Advertisement